Company Filing History:
Years Active: 2013-2014
Title: The Innovative Contributions of Padraic Curran
Introduction
Padraic Curran is a notable inventor based in Windsor, California. He has made significant contributions to the field of medical technology, particularly in catheter systems and targeted cell delivery methods. With a total of 2 patents, Curran's work has the potential to enhance therapeutic interventions in the vascular system.
Latest Patents
Curran's latest patents include innovative designs that address critical challenges in medical delivery systems. One of his patents focuses on "Cell reservoirs created by polymer plugs," which describes catheter systems used to deliver cells and other bioactive materials to specific locations within the vascular system. This invention aims to improve the precision and effectiveness of cell delivery in medical treatments. Another significant patent is the "Over-the-wire balloon catheter for efficient targeted cell delivery." This method involves advancing a balloon catheter to a treatment site, inflating the balloon, and delivering a primer that enhances the adherence of a therapeutic substance to the treatment site. This innovative approach aims to optimize the delivery of therapeutic substances, thereby improving patient outcomes.
Career Highlights
Throughout his career, Padraic Curran has worked with prominent companies in the medical technology sector. He has been associated with Medtronic Vascular, Inc. and Tyco Electronics Raychem Ireland. His experience in these organizations has contributed to his expertise in developing advanced medical devices and systems.
Collaborations
Curran has collaborated with talented professionals in his field, including Angela Duffy and Brendan Hanley. These collaborations have likely enriched his work and contributed to the success of his innovative projects.
Conclusion
Padraic Curran's contributions to medical technology through his patents and career experiences highlight his role as an influential inventor. His work continues to pave the way for advancements in targeted cell delivery systems, ultimately benefiting patients and the medical community.